BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14586400)

  • 1. Role of promoter methylation in regulation of the mammalian heparanase gene.
    Shteper PJ; Zcharia E; Ashhab Y; Peretz T; Vlodavsky I; Ben-Yehuda D
    Oncogene; 2003 Oct; 22(49):7737-49. PubMed ID: 14586400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase expression is associated with histone modifications in glioblastoma.
    Hong X; Nelson K; Lemke N; Kalkanis SN
    Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
    Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.
    Ogishima T; Shiina H; Breault JE; Terashima M; Honda S; Enokida H; Urakami S; Tokizane T; Kawakami T; Ribeiro-Filho LA; Fujime M; Kane CJ; Carroll PR; Igawa M; Dahiya R
    Oncogene; 2005 Oct; 24(45):6765-72. PubMed ID: 16007175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor p53 regulates heparanase gene expression.
    Baraz L; Haupt Y; Elkin M; Peretz T; Vlodavsky I
    Oncogene; 2006 Jun; 25(28):3939-47. PubMed ID: 16474844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
    Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modifications affect Dnmt3L expression.
    Aapola U; Mäenpää K; Kaipia A; Peterson P
    Biochem J; 2004 Jun; 380(Pt 3):705-13. PubMed ID: 15015937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
    Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK
    Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R; van Wert J; Bashambu M
    Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation.
    Dannenberg LO; Chen HJ; Tian H; Edenberg HJ
    Alcohol Clin Exp Res; 2006 Jun; 30(6):928-37. PubMed ID: 16737450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines.
    Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Kuroda M; Nagai N; Yanagi Y; Inoue T; Kawasaki S; Tanaka N; Matsubara N; Kishi K
    Oral Oncol; 2004 Jul; 40(6):597-603. PubMed ID: 15063388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
    Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
    Liu Z; Marquez M; Nilsson S; Holmberg AR
    Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
    Bhakat KK; Mitra S
    Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.